Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05 Disclosures
  • [Disclosure] SK hynix (000660 / SKHY) – Investor Relations (IR) Presentation / 2024-01-09 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · LTA · Supply Tightness / 2026-04-23 RESEARCH
  • [Disclosure] SK square (402340) – Removal of Subsidiary from Holding Company / 2025-11-28 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | AI Infrastructure · LTA · HBM Demand / 2026-06-09 RESEARCH
  • [Disclosure] Celltrion (068270) – CT-P51 (Keytruda Biosimilar) U.S. Phase 3 Clinical Trial Plan Amendment Filing / 2026-07-06 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Matters Related to Sustainability Report (Voluntary Disclosure) / 2026-06-29 Disclosures
  • [Research] Samsung Electro-Mechanics (009150) – SK Securities | MLCC Utilization · Supply Tightness · Margin Expansion / 2024-08-01 RESEARCH

[Disclosure] ISU PETASYS (007660) – Decision on Acquisition of Equity-Related Bonds / 2025-01-23

Posted on January 23, 2025August 1, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

ISU PETASYS has officially cancelled its plan to acquire KRW 42.0B worth of convertible bonds in JEIO, following a notice of termination served to the sellers due to their default on obligations under the Share Purchase Agreement.

📊 [Key Disclosure Details & Financial Summary]

  1. Reason for Amendment: Cancellation of the decision to acquire equity-related bonds.
  2. Details of Amendment: Notice of termination of the Share Purchase Agreement (SPA) sent to the sellers on January 23, 2025, due to non-performance of contractual obligations by the sellers, resulting in the withdrawal of the convertible bond acquisition.
  3. Originally Planned Acquisition Details (Cancelled):
  • Issuer: JEIO Co., Ltd.
  • Type of Bonds: 2nd Unregistered Unsecured Private Convertible Bonds
  • Principal Amount (Acquisition Amount): KRW 42.0B (KRW 42,000,000,000)
  • Original Expected Payment Date: March 07, 2025
  1. Details of Total Originally Planned Acquisition of JEIO (All Cancelled):
  • Share Purchase Agreement (Old Shares): 5,750,000 Common Shares / KRW 158.125B (KRW 158,125,000,000)
  • Third-Party Paid-in Capital Increase (New Shares): 5,460,000 Common Shares / KRW 99.69414B (KRW 99,694,140,000)
  • Convertible Bond Acquisition: Principal Amount of KRW 42.0B (KRW 42,000,000,000)

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Disclosure of Convertible Bond Acquisition Cancellation and Follow-up Status

The company served notice of SPA termination due to seller defaults and officially withdrew its decision to acquire JEIO convertible bonds. Monitoring subsequent disclosures regarding the cancelled acquisition plan is important to confirm the transaction status. Further details can be tracked through future periodic filings and related disclosures.

📢 Disclaimer & Source Notice

Source: This content has been newly structured and created based on official filing data from the Financial Supervisory Service DART system.

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific securities. All investment decisions and financial liabilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Semiconductors, Disclosures

Post navigation

Previous Post: [Disclosure] ISU PETASYS (007660) – Paid-in Capital Increase / 2025-01-23
Next Post: [Disclosure] ISU PETASYS (007660) – Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2025-01-23

Related Posts

  • [Disclosure] ALTEOGEN (196170) – Trading Suspension and Resumption of Stock Futures and Options / 2026-07-16 Disclosures
  • [Disclosure] Jusung Engineering (036930) – Decision on Conclusion of Trust Contract for Acquisition of Treasury Shares / 2024-10-29 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Decision on Stock Retirement / 2024-10-25 Semiconductors
  • [Disclosure] Hana Micron (067310) – (Correction) Decision on Corporate Split / 2025-04-22 Semiconductors
  • [Disclosure] Hana Micron (067310) – Additional Listing (Conversion of Domestic Private CB) / 2024-03-26 Disclosures
  • [Disclosure] ISU PETASYS (007660) – Setting of Record Date or Closing Period of Shareholder Register / 2024-11-18 Semiconductors
  • [Disclosure] Samsung Biologics (207940) – Advance Notice of Financial Results Announcement / 2025-07-09 Disclosures
  • [Disclosure] SK hynix (000660 / SKHY) – Decision on Acquisition of Shares and Investment Securities of Other Corporation (Correction Disclosure) / 2026-02-13 Semiconductors
  • [Disclosure] KEPCO (015760 / KEP) – Other Management Matters (Voluntary Disclosure) / 2024-02-26 Disclosures
  • [Disclosure] Hana Micron (067310) – New Listing of Preemptive Rights Certificates (Hana Micron 17R) / 2024-07-08 Semiconductors
  • [Disclosure] Samsung Electronics (005930) – Decision on Retirement of Shares / 2026-03-31 Semiconductors
  • [Disclosure] Celltrion (068270) – Approval of IND Amendment for CT-P55 (Cosentyx Biosimilar) U.S. Phase 3 Clinical Trial / 2026-05-12 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Legacy Memory Pricing · Earnings Upgrades · Volume Growth / 2026-03-03 RESEARCH
  • [Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract (Voluntary Disclosure) / 2025-11-27 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme